Eric Francois
CIK 1656125 · Chief Financial Officer · last filed 2026-04-21
Eric Francois is a Chief Financial Officer who has filed 13 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for PBAXW, was dated Apr 21, 2026. Across all open-market trades the lifetime net is +$49.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $49.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$49.6K
3
13
$49.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Director | — | $0.05 | — | $0 | 1 | 2026-04-21 |
| CervoMed Inc. (DFFN) Delisted | Director | — | $6.60 | — | $0 | 1 | 2021-07-06 |
| SCYX | Chief Financial Officer | 11,732 | $4.23 | $49.6K | $49.6K | 11 | 2021-02-02 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-21 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-06 | CervoMed Inc. (DFFN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-02 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2020-12-23 | SCYX | Mixed | +600 | $3.8K | EDGAR |
| 2020-12-04 | SCYX | Tax (F) | −4,459 | -$33.3K | EDGAR |
| 2020-02-04 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2019-02-19 | SCYX | Grant (A) | +125,000 | $0 | EDGAR |
| 2018-03-12 | SCYX | Buy (P) | +5,917 | $10.0K | EDGAR |
| 2018-02-13 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2017-02-02 | SCYX | Grant (A) | — | $0 | EDGAR |